A detailed history of Coppell Advisory Solutions Corp. transactions in Abb Vie Inc. stock. As of the latest transaction made, Coppell Advisory Solutions Corp. holds 1,212 shares of ABBV stock, worth $212,802. This represents 0.04% of its overall portfolio holdings.

Number of Shares
1,212
Previous 1,639 26.05%
Holding current value
$212,802
Previous $259 Million 14.76%
% of portfolio
0.04%
Previous 0.08%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $68,243 - $77,756
-427 Reduced 26.05%
1,212 $221 Million
Q1 2023

May 10, 2023

SELL
$144.61 - $166.54 $20,390 - $23,482
-141 Reduced 7.92%
1,639 $259 Million
Q4 2022

Feb 17, 2023

BUY
$138.31 - $165.87 $246,191 - $295,248
1,780 New
1,780 $288 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Coppell Advisory Solutions Corp. Portfolio

Follow Coppell Advisory Solutions Corp. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Coppell Advisory Solutions Corp., based on Form 13F filings with the SEC.

News

Stay updated on Coppell Advisory Solutions Corp. with notifications on news.